Moxonidine in combined therapy of essential arterial hypertension patients with chronic obstructive pulmonary disease

QR Code

Moxonidine in combined therapy of essential arterial hypertension patients with chronic obstructive pulmonary disease

Aim. To study moxonidine and calcium antagonist (amlodipine) effectiveness in essential arterial hypertension (EAH) treatment among patients with chronic obstructive pulmonary disease (COPD), and therapy effects on concomitant dyslipidemia. Material and methods. In total, 30 patients with EAH and St...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. R. Paleev, E. G. Shuganov, N. A. Raspopina, N. V. Vilchinskaja
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2006-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	moxonidine amlodipine chronic obstructive pulmonary disease essential arterial hypertension blood lipids
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1228
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ADDITIONAL BENEFITS OF ANTIHYPERTENSIVE MOXONIDINE THERAPY IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION
by: E. N. Dudinskaya, et al.
Published: (2014-02-01)

Amlodipine efficacy in patients with arterial hypertension and chronic obstructive pulmonary disease
by: A. I. Chesnikova, et al.
Published: (2005-08-01)

An imidazoline receptor agonist, moxonidine, in optimization of arterial hypertension treatment among postmenopausal women
by: A. B. Bakhshaliev, et al.
Published: (2006-02-01)

Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
by: V. V. Trusov, et al.
Published: (2007-08-01)

COMBINATION THERAPY WITH BISOPROLOL AND AMLODIPINE IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: V. A. Nikitin, et al.
Published: (2015-08-01)

EFFECTS OF CALCIUM ANTAGONISTS OF THE THIRD GENERATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: D. A. Yakhontov, et al.
Published: (2016-01-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01)

EFFICACY AND SAFETY OF AMLODIPINE MALEATE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND BRONCHIAL ASTHMA WITH CONCOMITANT ARTERIAL HYPERTENSION
by: N. A. Karoli, et al.
Published: (2016-01-01)

THE USE OF GENERIC MOXONIDINE IN SYSTEMIC BLOOD PRESSURE ELEVATION
by: B. B. Ruksin, et al.
Published: (2015-08-01)

Amlodipine therapy effects on quality of life in patients with essential arterial hypertension
by: N. N. Ilov, et al.
Published: (2012-10-01)

Moxonidine-based combination antihypertensive therapy in patients with metabolic syndrome
by: E. V. Tishina, et al.
Published: (2012-06-01)

COGNITIVE-MNESTIC FUNCTIONS IN ABLE-BODIED AGED PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION IN AMLODIPINE TREATMENT
by: N. N. Ilov, et al.
Published: (2016-01-01)

ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS
by: T. V. Adasheva, et al.
Published: (2016-01-01)

EFFECTIVENESS OF PERINDOPRIL AND AMLODIPINE COMBINATION IN HYPERTENSIVES WITH COPD
by: O. N. Kryuchkova, et al.
Published: (2014-11-01)

Hypertension in periand postmenopausal women: mechanisms, management, observation
by: E. A. Polyakova, et al.
Published: (2024-02-01)

Assessment of in Vitro Comparative Dissolution Kinetics of Moxonidine Products as a Factor Potentially Determining Effectiveness of Antihypertensive Treatment
by: G. V. Ramenskaya, et al.
Published: (2019-01-01)

SMOKING’S ROLE IN THE PATHOGENESIS OF BRONCHIAL AND SYSTEMIC INFLAMMATION AT THE INITIAL STAGE COPD
by: A. E. Shuganov, et al.
Published: (2017-04-01)

Hypertension in peri- and postmenopausal women — pathophysiological mechanisms and approaches to treatment
by: E. I. Baranova, et al.
Published: (2023-06-01)

Optimization of Pharmacotherapy Within the Framework of a Patient-oriented Approach in the Treatment of Hypertension in Multimorbidity Patients (Clinical Case and Literature Review)
by: O. D. Ostroumova, et al.
Published: (2021-03-01)

Carotid artery remodelling in patients with chronic obstructive pulmonary disease
by: E. G. Akramova
Published: (2013-02-01)

COMPARATIVE STUDY OF EFFICIENCY AND SAFETY OF THE NEW DRUG OF AMLODOPINE – S-AMLODOPINE IN PATIENTS WITH ARTERIAL HYPERTENSION OF I-II DEGREE
by: M. A. Maksimova, et al.
Published: (2016-01-01)

Moexipril effects on lung function in patients with arterial hypertension and chronic obstructive pulmonary disease
by: N. V. Ivanova, et al.
Published: (2006-02-01)

ECOLOGICAL STRESS AND ITS EFFECTS ON ESSENTIAL HYPERTENSION AND CHRONIC OBSTRUCTIVE BRONCHITIS DEVELOPMENT IN ROSTOV-ON-DON INHABITANTS
by: L. I. Katelnitskaya, et al.
Published: (2015-12-01)

Influence of asilsartan medoxomile on arterial hypertension variability in patients with arterial hypertension and chronic obstructive pulmonary disease
by: N. Yu. Grigorieva, et al.
Published: (2021-06-01)

Pharmacotherapy efficacy assessment in arterial hypertension with metabolic disturbances
by: A. A. Demin, et al.
Published: (2005-06-01)

CHANGES IN THE PARAMETERS OF 24-HOUR BLOOD PRESSURE MONITORING AND ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH VALSARTAN
by: N. A. Karoli, et al.
Published: (2015-09-01)

CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION: VASCULAR WALL AS THE TARGET ORGAN IN COMORBID PATIENTS
by: N. A. Karoli, et al.
Published: (2017-09-01)

SLEEP MEDICINE AND ESSENTIAL HYPERTENSION IN ADOLESCENTS
by: O. N. Berdina
Published: (2014-04-01)

THROMBOPHILIA AND INTENSITY OF THE INTRAVASCULAR MICROCOAGULATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROTHROMBOSIS
by: E. A. Shelest, et al.
Published: (2015-09-01)

EFFECTIVENESS OF THE PULMONARY REHABILITATION PROGRAMME IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND OBESITY
by: Evgeny S. Ovsyannikov, et al.
Published: (2019-07-01)

INFLUENCE OF PULMONARY HYPERTENSION ON CLINICAL COURSE AND PROGNOSIS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: S. N. Avdeev, et al.
Published: (2018-07-01)

AGE-RELATED FEATURES OF COMMON CAROTID ARTERIES IN PATIENTS WITH ARTERIAL HYPERTENSION, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND THEIR COMBINATION
by: O. V. Milyutina, et al.
Published: (2010-06-01)

BLOOD FLOW DISTRIBUTION IN ESSENTIAL HYPERTENSION
by: B. F. Lukyanov, et al.
Published: (2002-10-01)

Improving the cognitive functions in the middle-aged patients with essential arterial hypertension after the treatment with amlodipine/valsartan single-pill combination
by: O. D. Ostroumova, et al.
Published: (2019-03-01)

METHOD FOR THE PREDICTION OF THE DEVELOPMENT OF CHRONIC PULMONARY HEART IN COAL WORKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: O. Yu. Korotenko, et al.
Published: (2013-05-01)

The level of plasma renin activity in patients with combination of chronic obstructive pulmonary disease and arterial hypertension
by: E. L. Selezneva, et al.
Published: (2021-06-01)

Anxiety-depressive syndrome in patients with arterial hypertension and chronic obstructive pulmonary disease with frequent exaccations
by: L. A. Shpagina, et al.
Published: (2023-11-01)

The impact of chronic obstructive pulmonary disease and hypertension on the development and progression of atrial fibrillation
by: L. D. Khidirova, et al.
Published: (2019-11-01)

Features of clinical-functional parameters of the heart, vessels and microcirculation in patients with arterial hypertension in the combination to chronic obstructive pulmonary diseases
by: I. S. Shpagin, et al.
Published: (2010-12-01)

Clinical, cardio-hemodynamical, and respiratory effects of ACE inhibitor cilazapril in patients with arterial hypertension and chronic obstructive pulmonary disease
by: L. I. Olbynskaya, et al.
Published: (2005-02-01)